Atlas Trials

Expanded Access to Telisotuzumab Vedotin

Clinical trial NCT04830202 · TEMPORARILY_NOT_AVAILABLE

Trial details

NCT number
NCT04830202
Sponsor
AbbVie
Status
TEMPORARILY_NOT_AVAILABLE
Study type
EXPANDED_ACCESS
Non-Small Cell Lung Cancer (NSCLC)

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.